Filed with the SEC on · Summarized by InvestorsBot
Kevin Sayer, Dexcom’s executive chair and a director, sold 26,756 shares in three open-market transactions on August 20, 2026. He sold 19,308 shares at $89.71, 7,351 at $90.78, and 97 at $91.41, for approximately $2.41 million total; his reported holdings fell to 309,662, 302,311, and 302,214 shares, respectively.
Pick up to 20 companies — we read their SEC filings overnight and send you the plain-English version. Free.
Subscribe freeDexCom reports 13% revenue growth and raises 2026 margin guidance
8-K · July 30, 2026
Dexcom Executive Chair Kevin Sayer sells $2.0M in stock
Form 4 · Insider Trade · July 21, 2026
DexCom files 8-K (Item 9.01): Exhibit 10.1 — Letter Agreement dated Feb 27, 2026 between DexCom, Inc.
8-K · March 2, 2026
Kevin R.
8-K · March 2, 2026
Dexcom filed Form 8‑K on Feb 26, 2026: Item 9.01 lists Exhibit 99.1 (press release dated Feb 26, 2026) and…
8-K · February 26, 2026
Dexcom ($DXCM) announced on Feb 26, 2026 the appointment of Mr.
8-K · February 26, 2026